The role of mesalamine in the treatment of ulcerative colitis.

about

Chest pain in a 12-year-old girl with ulcerative colitis after therapy with mesalazine Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.An unusual cause of febrile hepatitis.

P2860

Q36986634-B1016A25-A30C-4689-B048-D6E188F2E1F9 Q36997021-D79DC11A-1C16-4F1D-9D4C-2D6E48422122 Q40149987-3AE428B0-CAD6-4FA0-9345-31FAC90285B3

P2860

The role of mesalamine in the treatment of ulcerative colitis.

Item

http://www.wikidata.org/entity/Q36645826

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The role of mesalamine in the treatment of ulcerative colitis.

@ast

The role of mesalamine in the treatment of ulcerative colitis.

@en

type

Item

label

The role of mesalamine in the treatment of ulcerative colitis.

@ast

The role of mesalamine in the treatment of ulcerative colitis.

@en

prefLabel

The role of mesalamine in the treatment of ulcerative colitis.

@ast

The role of mesalamine in the treatment of ulcerative colitis.

@en

P1476

The role of mesalamine in the treatment of ulcerative colitis

@en

P2093

Raffi Karagozian

http://www.w3.org/2001/XMLSchema#string

Robert Burakoff

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

Inflammatory Bowel Disease

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes.

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Familial occurrence of inflammatory bowel disease.

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.

Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis.

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

P304

893-903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18473013

http://www.w3.org/2001/XMLSchema#string

P932

2376091

http://www.w3.org/2001/XMLSchema#string

The role of mesalamine in the treatment of ulcerative colitis.

about

P2860

P2860

The role of mesalamine in the treatment of ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932